Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;35(7):e425-e427.
doi: 10.1111/jdv.17250. Epub 2021 Apr 19.

Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. 'COVID-arm': a clinical and histological characterization

D Fernandez-Nieto  1 , J Hammerle  2 , M Fernandez-Escribano  2 , C M Moreno-Del Real  3 , P Garcia-Abellas  3 , I Carretero-Barrio  3 , E Solano-Solares  4 , B de-la-Hoz-Caballer  4 , J Jimenez-Cauhe  1 , D Ortega-Quijano  1 , M Fernandez-Guarino  1
Affiliations

Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. 'COVID-arm': a clinical and histological characterization

D Fernandez-Nieto et al. J Eur Acad Dermatol Venereol. 2021 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

Figure 1
Figure 1
(a) A 34‐year‐old female healthcare worker showing a slightly indurated erythematous targetoid patch at the injection‐site reaction of 6 × 4.5 cm diameter, 8 days after the first dose of the BNT162b2 vaccine. (b) Histologic examination shows a superficial and deep perivascular lymphocytic infiltrate (H‐E ×100). (c) Close‐up examination shows dilated vessels, repleted with intraluminal neutrophils. An increased number of eosinophils or mast cells was not present (H‐E ×400).
See this image and copyright information in PMC

References

    1. Galván Casas C, Català A, Carretero Hernández G et al. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020; 183: 71–77. 10.1111/bjd.19163 - DOI - PMC - PubMed
    1. Marzano AV, Genovese G, Moltrasio C et al. The clinical spectrum of COVID‐19‐associated cutaneous manifestations: an Italian multicentre study of 200 adult patients. J Am Acad Dermatol 2021; 84: 1356–1363. 10.1016/j.jaad.2021.01.023 - DOI - PMC - PubMed
    1. Garrido Ruiz MC, Santos‐Briz Á, Santos‐Briz Á et al. Spectrum of clinicopathologic findings in COVID‐19‐induced skin lesions: demonstration of direct viral infection of the endothelial cells. Am J Surg Pathol 2021; 45: 293–303. - PubMed
    1. Zhang Y, Cao W, Xiao M et al. Clinical and coagulation characteristics in 7 patients with critical COVID‐2019 pneumonia and acro‐ischemia. Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi 2020; 41: 302–307. - PMC - PubMed
    1. Kolivras A, Dehavay F, Delplace D et al. Coronavirus (COVID‐19) infection‐induced chilblains: a case report with histopathologic findings. JAAD Case Rep 2020; 6: 489–492. - PMC - PubMed